Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

CompletedOBSERVATIONAL
Enrollment

166,613

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

linagliptin

non-randomized

Trial Locations (1)

Unknown

Boehringer Ingelheim Investigational Site, Boston

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY